One study demonstrated that bisdemethoxycurcumin in combination with PD-L1 blockades significantly increased CD8+ T-cell tumor infiltration, increased IFN-γ, and granzyme B. These changes were associated with increased survival in nude mice that had bladder cancer metastasis [117]. This evidence concerns the gene CD8A and neoplasm.